Cardiol Therapeutics (CRDL) Receivables - Other: 2021-2022
Historic Receivables - Other for Cardiol Therapeutics (CRDL) over the last 2 years, with Sep 2022 value amounting to $33,301.
- Cardiol Therapeutics' Receivables - Other rose 142.07% to $33,301 in Q3 2022 from the same period last year, while for Sep 2022 it was $33,301, marking a year-over-year increase of 142.07%. This contributed to the annual value of $272,412 for FY2021, which is N/A change from last year.
- According to the latest figures from Q3 2022, Cardiol Therapeutics' Receivables - Other is $33,301, which was down 32.76% from $49,527 recorded in Q2 2022.
- In the past 5 years, Cardiol Therapeutics' Receivables - Other registered a high of $270,835 during Q4 2021, and its lowest value of -$290,047 during Q2 2021.
- In the last 2 years, Cardiol Therapeutics' Receivables - Other had a median value of -$44,567 in 2022 and averaged -$15,081.
- Data for Cardiol Therapeutics' Receivables - Other shows a peak YoY soared of 142.07% (in 2022) over the last 5 years.
- Cardiol Therapeutics' Receivables - Other (Quarterly) stood at $270,835 in 2021, then soared by 142.07% to $33,301 in 2022.
- Its last three reported values are $33,301 in Q3 2022, $49,527 for Q2 2022, and -$44,567 during Q1 2022.